Skinny label concerns persist for generics, despite good news from Delaware
A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.